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The impact of CYP2C19 polymorphism on platelet
reactivity for guiding clopidogrel treatment and
cost analysis
Almeman Ahmad, Khalaf Hassan, Rasool Semaab,
Moataz Dowaidar, Al Orainy Mohammad
Intervention Group at Prince Sultan Cardiac Center,
Qassim & Genetic Laboratory at Qassim University
Background There has been a weak recommendation
for routine genetic and Platelet function testing by the
American college of cardiologists (ACC) for patients
receiving clopidogrel.
Aim To investigate the variability in PFT response to
CYP2C19 polymorphism and conduct a cost analysis.
Methodology Eighty six Saudi patients who were sta-
ble on 75 mg clopidogrel at least for one month for vari-
ous cardiac indications were enrolled. Genotyping by
real-time polymerase chain reaction (PCR) and PFT was
carried out (Verify Now P2Y12) for all the patients.
Results Fifty three patients presented with the wild
variant 1/1, 13 patients with 1/2, and 20 patients with
2/2. We could not detect allele 3 probably as our sample
was small. There is a significant association between dif-
ferent genotyping and the percentage of inhibition
(P = 0.0002). 1/1 patients tend to be moderate-to-exten-
sive metabolizers, whereas the majority of the rest are
slow metabolizers. Forty eight patients presented with
no symptoms suggestive for atherothrombotic events,
and the rest complained of non-specific symptoms. Inter-
estingly, proton-pump inhibitors, mainly Omeprazole,
did not affect the overall rate of inhibition (P = 0.60).
The cost of doing the PFT is 250 SR/ patient and 200
SR/patient (real-time PCR) for kits and materials exclud-
ing equipments and labors. Equipments may change
considerably according to the purchased technology.
Conclusion The PFT varied significantly according to
the polymorphism. The cost of PFT and or genotyping is
reasonable if the equipments are accessible.
http://dx.doi:10.1016/j.jsha.2013.03.005
Multidetector CT angiography as a noninvasive
tool to assess graft patency of surgically
reconstructed diffusely diseased coronary artery
Ahmed Rezk, Mohamed Bazid, Zizi Saad
Background: Long reconstruction of the diffusely
diseased vessel may be useful surgical option for patients
with diffuse coronary artery disease. Close and careful
follow up of such subgroup of patients is mandatory.
Invasive graft angiography serves as the diagnostic stan-
dard for follow up of graft patency for such extensive pro-
cedure; however, because of the risks, discomfort, and
costs of a hospital stay, a noninvasive diagnostic tool is
desirable. MDCT angiography is a noninvasive and safe
alternative to assess graft patency in patients after CABG
with reconstructed diffusely diseased vessels.
Methods: 25 patients with the diffusely diseased LAD
underwent long-segmental reconstruction procedurewith
a LITA graft. The diffusely diseased LAD was extensively
incised, additional endarterectomy was performed if nec-
essary, and then the LAD was reconstructed with an ITA
graft in a long on-lay fashion. Postoperative MDCT angi-
ography as a non-invasive single tool was performed in
25 asymptomatic patients to assess graft patency.
Results: The cohort consisted of 23 men (92%) and 2
women (8%). The mean age was 58.5 ± 9.2 years. The
mean length of the arteriotomy incision was
3.5 ± 1.2 cm. Endarterectomy was performed in 3 patients
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